Breast Neoplasms Clinical Trials in Guangzhou, Guangdong
13 recruitingGuangzhou, Guangdong, China
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Breast Neoplasms
Merck Sharp & Dohme LLC1,000 enrolled149 locationsNCT07060807
Recruiting
Phase 3
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC2,400 enrolled234 locationsNCT06966700
Recruiting
Phase 3
Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer
Breast Neoplasms
Sun Yat-sen University192 enrolled1 locationNCT07088263
Recruiting
Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer
Breast NeoplasmsHER2-low Breast CancerAntibody-drug Conjugates
Sun Yat-sen University700 enrolled1 locationNCT06877416
Recruiting
Not Applicable
Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled Trial
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University566 enrolled1 locationNCT06024187
Recruiting
Not Applicable
Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge
Breast NeoplasmsNipple Discharge
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University88 enrolled1 locationNCT05812040
Recruiting
Phase 3
Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University375 enrolled1 locationNCT06313463
Recruiting
Not Applicable
Minimal Access Versus Conventional Latissimus Dorsi Flap Harvest for Breast Reconstruction
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University94 enrolled1 locationNCT06319157
Recruiting
Phase 1
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University24 enrolled1 locationNCT06121570
Recruiting
Phase 1
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University24 enrolled1 locationNCT06121557
Recruiting
Phase 1Phase 2
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University170 enrolled1 locationNCT05981001
Recruiting
Phase 1Phase 2
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University196 enrolled1 locationNCT05981014
Recruiting
Not Applicable
Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer
Breast Neoplasms
Liao Ning222 enrolled1 locationNCT02389673